Chenyu Pi - Concepedia

Concepedia

Author

Chenyu Pi

Tongji University ORCID

Also Known As

Chenyu Pi

10

Publications

180

Citations

8

H-Index

23

Concepts

All Affiliations

Tongji University Tongji Hospital Henan University of Science and Technology Suzhou Research Institute Sichuan University

CP

About

Chenyu Pi is an author at Tongji University specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	113
2	Immunology	5	5	113
3	Cell Biology	4	4	62
4	Drug Resistance	1	1	14
5	Humoral Immunity	1	1	14

Chenyu Pi

×

8

Publications

173

Citations

8

H-Index

	Year	Citations
A HER2 target antibody drug conjugate combined with anti-PD-(L)1 treatment eliminates hHER2+ tumors in hPD-1 transgenic mouse model and contributes immune memory formation Lei Huang, Ruiqin Wang, Kun Xie, Breast Cancer Research and Treatment Cancer ImmunosurveillanceTreatment EliminatesImmunologyImmunoeditingImmune Checkpoint Inhibitor	2021	51
CD89-mediated recruitment of macrophages via a bispecific antibody enhances anti-tumor efficacy Bingyu Li, Lijun Xu, Chenyu Pi, OncoImmunology	2017	33
Simultaneous exposure to FcγR and FcαR on monocytes and macrophages enhances antitumor activity<i>in vivo</i> Bingyu Li, Lijun Xu, Fei Tao, Oncotarget Immune RegulationImmunologyImmunologic MechanismImmunotherapeuticsImmune Cell Therapy	2017	22
Neo-intline: integrated pipeline enables neoantigen design through the in-silico presentation of T-cell epitope Bingyu Li, Jing Ping, Genhui Zheng, Signal Transduction and Targeted Therapy	2023	15
A Novel Anti-B7-H3 × Anti-CD3 Bispecific Antibody with Potent Antitumor Activity Feng Yan, Kun Xie, Yanxin Yin, Life ImmunologyImmunoeditingImmunotherapeuticsImmunotherapyTumor Biology	2022	14
Reversing PD-1 Resistance in B16F10 Cells and Recovering Tumour Immunity Using a COX2 Inhibitor Chenyu Pi, Jing Ping, Bingyu Li, Cancers ImmunologyImmunotherapeuticsImmunotherapyCancer BiologyTumor Biology	2022	14
Adaptive resistance in tumors to anti-PD-1 therapy through re-immunosuppression by upregulation of GPNMB expression Xiaoqing Xu, Kun Xie, Bingyu Li, International Immunopharmacology Cancer ImmunosurveillanceAnti-pd-1 TherapyMedicineGpnmb ExpressionImmunology	2021	12
Targeting CD89 on tumor-associated macrophages overcomes resistance to immune checkpoint blockade Lijun Xu, Bingyu Li, Chenyu Pi, Journal for ImmunoTherapy of Cancer	2022	12

Page 1